fashion -WSS

fashion

author：Wikipedia 2025-09-06 03:33:14 - browse：3

Johnson & Johnson sign — MARK RALSTON/AFP via Getty Images

WASHINGTON — Pharmaceutical giant Johnson & Johnson on Tuesday became the third drugmaker to sue the Biden administration over its new Medicare drug price negotiation program.

J&J joins a flurry of litigation challenging the Medicare drug price negotiation program, which is set to start this fall. Merck, Bristol Myers Squibb, the brand-drug lobby PhRMA, and the U.S. Chamber of Commerce have also filed suit. The negotiated prices would go into effect in 2026.

The company argued that it is entitled to sue because its blockbuster blood thinner drug Xarelto may be up for negotiation in the first round of ten drugs Medicare will examine, but that list is not set to be announced officially until Sept. 1.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： FogPharma raises $145 million in rare Series E round

WSS

See Ryan Reynolds, Hugh Jackman suited up in 1st look at 'Deadpool 3': Photo

Dozens of beaches across Northeast closed for swimming due to high levels of bacteria in water

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Dozens of beaches across Northeast closed for swimming due to high levels of bacteria in water

RSV vaccines may be linked to small increased risk of developing GBS

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

leisure time

fashion

focus

After affirmative action ruling, medical educators look to 'holistic review'

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

Alkermes shareholders re

FogPharma raises $145 million in rare Series E round

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Giraffe named Twiga, who was among the oldest cared for by humans, died at age 31 at East Texas zoo

Hollywood unions extend contract negotiations for actors

Why getting cancer drugs just got harder for rural patients

Medical leaders decry Supreme Court decision on affirmative action

ALS groups 'won't be played again' by the FDA, drug sponsors

hotspot

RaDonda Vaught to speak at CommonSpirit event on patient safety

Parents surprise family after baby discharged from NICU after 170 days

Biden’s NIH nominee is languishing in Congress

Dozens of beaches across Northeast closed for swimming due to high levels of bacteria in water

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Accuser who called Kevin Spacey 'vile sexual predator' admits he joked about incident

knowledge

focus

hotspot

knowledge